MedTrace Logo

A Study to Evaluate the Safety and Pharmacokinetics of NVP-1402

NCT02897726 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2017-08-08

No results posted yet for this study

Summary

The purpose of this study is to evaluate and compare the safety and pharmacokinetics of NVP-1402 and NVP-1402R in healthy male subjects.

Conditions

  • Healthy

Interventions

DRUG

NVP-1402

Oral

DRUG

NVP-1402R

Oral

Sponsors & Collaborators

  • NVP Healthcare

    lead INDUSTRY

Principal Investigators

  • Young-Ran Yoon, M.D.,Ph.D. · Kyungpook National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-24
Primary Completion
2017-07-03
Completion
2017-07-03

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02897726 on ClinicalTrials.gov